Neuroprotective properties of a novel, non-haematopoietic agonist of the erythropoietin receptor.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Brain : a journal of neurology

• Publication date

  2010-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/brain/awq101PMID 20435631
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin or darbepoetin for patients with cancer.

  2012cited by this paper
• Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system

  2011influential reference
• Optimal neuroprotection by erythropoietin requires elevated expression of its receptor in neurons

  2009cited by this paper
• Erythropoietin receptor expression is concordant with erythropoietin but not with common β chain expression in the rat brain throughout the life span

  2009cited by this paper
• A metallothionein mimetic peptide protects neurons against kainic acid‐induced excitotoxicity

  2009cited by this paper
• Erythropoietin as a neuroprotective agent in traumatic brain injury Review.

  2009cited by this paper
• Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin

  2008cited by this paper
• Erythropoietin reduces epileptogenic processes following status epilepticus

  2008cited by this paper
• Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

  2008cited by this paper
• Effect of age on kainate-induced seizure severity and cell death.

  2008cited by this paper
• Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.

  2008cited by this paper
• Identification of NCAM‐binding peptides promoting neurite outgrowth via a heterotrimeric G‐protein‐coupled pathway

  2007cited by this paper
• Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low‐density lipoprotein receptor family

  2007cited by this paper
• Neuroprotective effects of erythropoietin in the rat hippocampus after pilocarpine-induced status epilepticus.

  2007cited by this paper
• A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.

  2007cited by this paper
• Molecular Mechanisms of Ca2+ Signaling in Neurons Induced by the S100A4 Protein

  2006cited by this paper
• Biophysical comparability of the same protein from different manufacturers: a case study using Epoetin alfa from Epogen and Eprex.

  2006cited by this paper
• Erythropoietin or darbepoetin for patients with cancer.

  2006cited by this paper
• Erythropoietin and Normal Brain Development: Receptor Expression Determines Multi-Tissue Response

  2006cited by this paper
• Regional neuropathology following kainic acid intoxication in adult and aged C57BL/6J mice.

  2006cited by this paper
• A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention.

  2006cited by this paper
• New avenues of exploration for erythropoietin.

  2005cited by this paper
• Emerging biological roles for erythropoietin in the nervous system

  2005cited by this paper
• The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin

  2005cited by this paper
• Emerging biological roles for erythropoietin in the nervous system

  2005influential reference
• Erythropoietin and the hypoxic brain

  2004cited by this paper
• Treatment of Stroke With Erythropoietin Enhances Neurogenesis and Angiogenesis and Improves Neurological Function in Rats

  2004cited by this paper
• Erythropoietin: a candidate compound for neuroprotection in schizophrenia

  2004cited by this paper
• Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic

  2004cited by this paper
• Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor.

  2004cited by this paper
• The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events.

  2004cited by this paper
• An NCAM‐derived FGF‐receptor agonist, the FGL‐peptide, induces neurite outgrowth and neuronal survival in primary rat neurons

  2004cited by this paper
• Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal Apoptosis

  2003cited by this paper
• Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo

  2003cited by this paper
• Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

  2003cited by this paper
• Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats.

  2002cited by this paper
• Erythropoietin receptor signalling is required for normal brain development.

  2002cited by this paper
• Induction of Neuronal Differentiation by a Peptide Corresponding to the Homophilic Binding Site of the Second Ig Module of the Neural Cell Adhesion Molecule*

  2002influential reference
• Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an In Vitro Model

  2002cited by this paper
• Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia*

  2001cited by this paper
• Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

  2001cited by this paper
• Hematopoietic Growth Factor Mimetics

  2001cited by this paper
• A simple procedure for quantification of neurite outgrowth based on stereological principles.

  2000cited by this paper
• Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury.

  2000cited by this paper
• Neural Cell Adhesion Molecule-Stimulated Neurite Outgrowth Depends on Activation of Protein Kinase C and the Ras–Mitogen-Activated Protein Kinase Pathway

  2000cited by this paper
• Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide*

  1999cited by this paper
• Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery.

  1998cited by this paper
• In vivo evidence that erythropoietin protects neurons from ischemic damage.

  1998cited by this paper
• Efficiency of signalling through cytokine receptors depends critically on receptor orientation

  1998cited by this paper
• Deciphering protein sequence information through hydrophobic cluster analysis (HCA): current status and perspectives

  1997cited by this paper
• Characterization of microwell cultures of dissociated brain tissue for studies of cell‐cell interactions

  1997cited by this paper
• Mapping of the active site of recombinant human erythropoietin.

  1997cited by this paper
• Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death.

  1996cited by this paper
• Functional Mimicry of a Protein Hormone by a Peptide Agonist: The EPO Receptor Complex at 2.8 Å

  1996cited by this paper
• A sequential dimerization mechanism for erythropoietin receptor activation.

  1996cited by this paper
• Erythropoietin structure-function relationships. Identification of functionally important domains.

  1994cited by this paper
• Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP.

  1993cited by this paper
• Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo.

  1993cited by this paper
• Improvements in protein secondary structure prediction by an enhanced neural network.

  1990cited by this paper
• Characterization of recombinant human erythropoietin produced in Chinese hamster ovary cells.

  1987cited by this paper
• Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy.

  1985cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper

• Non-hematopoietic erythropoietin splice variant is produced in the diseased human brain and confers neuroprotection

  2026cites this paper
• Elucidating the Pivotal Neuroprotective Mechanisms and Therapeutic Variants of Erythropoietin in Neonatal Brain Injury.

  2025cites this paper
• Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection.

  2024cites this paper
• Is the β Common Receptor the Key Molecule for the Protective Effect of Erythropoietin?

  2023cites this paper
• Introducing the brain erythropoietin circle to explain adaptive brain hardware upgrade and improved performance

  2022cites this paper
• Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study

  2022cites this paper
• Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders

  2022cites this paper
• Erythropoietin and Non-Erythropoietic Derivatives in Cognition

  2021cites this paper
• The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice

  2021cites this paper
• Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection

  2021cites this paper
• Reply to Comment on Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro.

  2021cites this paper
• A Novel Plant-Produced Asialo-rhuEPO Protects Brain from Ischemic Damage Without Erythropoietic Action

  2021cites this paper
• Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer’s disease

  2021cites this paper
• Erythropoietin and derivatives: Potential beneficial effects on the brain

  2021influential citation
• Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy

  2021cites this paper
• The involvement of nuclear factor‐κB in astroprotection against ischemia‐reperfusion injury by ischemia‐preconditioned neurons

  2021cites this paper
• Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro.

  2020cites this paper
• Neurotrophic effects of vascular endothelial growth factor B and novel mimetic peptides on neurons from the central nervous system.

  2020cites this paper
• FGF2 and dual agonist of NCAM and FGF receptor 1, Enreptin, rescue neurite outgrowth loss in hippocampal neurons expressing mutated huntingtin proteins

  2019cites this paper
• Short erythropoietin-derived peptide enhances memory, improves long-term potentiation, and counteracts amyloid beta-induced pathology.

  2019cites this paper
• Recombinant asialoerythropoetin protects HL-1 cardiomyocytes from injury via suppression of Mst1 activation

  2019cites this paper
• Cell-free protein synthesis as a novel tool for directed glycoengineering of active erythropoietin

  2018cites this paper
• Peptide Derivatives of Erythropoietin in the Treatment of Neuroinflammation and Neurodegeneration.

  2018cites this paper
• Non-arteritic anterior ischemic optic neuropathy – Case report

  2018cites this paper
• The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival

  2018cites this paper
• Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor

  2017influential citation
• Erythropoietin in bone – Controversies and consensus

  2017cites this paper
• Context-Dependent Skeletal Effects of Erythropoietin.

  2017cites this paper
• Erythropoietin diminishes isoflurane‐induced apoptosis in rat frontal cortex

  2016cites this paper
• Epobis is a Nonerythropoietic and Neuroprotective Agonist of the Erythropoietin Receptor with Anti-Inflammatory and Memory Enhancing Effects

  2016influential citation
• Neuroprotective Effects of an Erythropoietin-Derived Peptide in PC1 2 Cells under Oxidative Stress.

  2016cites this paper
• Emtins : novel peptides derived from metallothionein-II as potential therapeutics in Alzheimer's disease

  2016cites this paper
• Neonatal brain injury as a consequence of insufficient cerebral oxygenation.

  2016cites this paper
• Are high cumulative doses of erythropoietin neuroprotective in preterm infants? A two year follow-up report

  2015cites this paper
• Neuroprotective agents and modulation of temporal lobe epilepsy.

  2015cites this paper
• Agonists of the tissue-protective erythropoietin receptor in the treatment of Parkinson's disease.

  2015cites this paper
• Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy

  2015cites this paper
• Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection.

  2014cites this paper
• Promoting stroke recovery using delayed growth factor delivery: Contribution of ipsilesional versus contralesional pyramidal tract plasticity

  2014cites this paper
• Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist

  2014cites this paper
• Erythropoietin and cytoprotective cytokines in experimental traumatic brain injury.

  2013cites this paper
• What is the Role of Erythropoietin in Acute Myocardial Infarct? Bridging the Gap Between Experimental Models and Clinical Trials

  2013cites this paper
• Erythropoietin: a neuroprotective agent in cerebral hypoxia, neurodegeneration, and epilepsy.

  2013cites this paper
• Vascular growth factors in neuropsychiatry

  2013cites this paper
• The CNTF-derived peptide mimetic Cintrofin attenuates spatial-learning deficits in a rat post-status epilepticus model.

  2013cites this paper
• Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants

  2013cites this paper
• A new agonist of the erythropoietin receptor, Epobis, induces neurite outgrowth and promotes neuronal survival

  2012influential citation
• Erythropoietin stimuliert die Knochenheilung der Maus

  2012cites this paper
• Chapter 4 – Nonhematopoietic Effects of Erythropoietin

  2012cites this paper
• Preterm Birth - Mother and Child

  2012cites this paper
• The Protective Role of Erythropoietin in the Developing Brain

  2012cites this paper
• The metastasis-promoting S100A4 protein confers neuroprotection in brain injury

  2012cites this paper
• Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?

  2012cites this paper
• Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM.

  2012cites this paper
• Erythropoietin Enhances Nerve Repair in Anti-Ganglioside Antibody-Mediated Models of Immune Neuropathy

  2011influential citation
• Intranasal erythropoietin therapy in nervous system disorders

  2011cites this paper
• Erythropoietin in neonatal brain protection: the past, the present and the future.

  2011cites this paper
• A screen for peptide agonists of the G-CSF receptor

  2011cites this paper
• Impact of the erythropoietin-derived peptide mimetic Epotris on the histopathological consequences of status epilepticus.

  2011cites this paper
• Aus dem Department für Veterinärwissenschaften der Tierärztlichen Fakultät der Ludwig-Maximilians-Universität München

  2011cites this paper
• Post-acute delivery of erythropoietin induces stroke recovery by promoting perilesional tissue remodelling and contralesional pyramidal tract plasticity.

  2011cites this paper
• Erythropoietin for neonatal brain injury: opportunity and challenge

  2011cites this paper
• The erythropoietin‐derived peptide mimetic pHBSP affects cellular and cognitive consequences in a rat post–status epilepticus model

  2011cites this paper
• Non-erythroid effects of erythropoietin

  2010cites this paper
• Novel discoveries in understanding the complexities of epilepsy and major depression

  2010cites this paper
• Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research.

  2010cites this paper
• Autoimmune lymphoproliferative syndrome: a multifactorial disorder

  2010cites this paper